Cancer genetics, inc (CGIX)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Revenue

28,420

26,886

26,642

27,470

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

27,947

27,049

25,303

22,554

19,738

18,040

16,591

15,811

13,138

10,199

8,018

6,501

6,821

6,610

5,831

5,368

4,685

4,301

0

0

0

Cost of revenues

18,404

18,129

18,279

18,724

11,881

15,784

18,943

18,070

17,103

16,959

17,210

17,104

17,589

16,248

15,060

14,098

12,435

11,897

10,303

8,453

6,723

5,368

5,145

4,925

4,609

4,369

4,175

3,928

0

0

0

Gross profit (loss)

10,016

8,757

8,363

8,746

5,125

8,715

10,879

11,051

11,725

10,591

10,737

9,945

7,714

6,306

4,678

3,942

4,155

3,914

2,834

1,746

1,295

1,132

1,676

1,685

1,221

999

509

372

0

0

0

Operating expenses:
Research and development

-

2,252

2,261

-

-

3,387

4,360

4,789

4,241

4,854

5,545

5,967

5,953

6,161

5,737

5,483

5,865

5,453

5,303

4,622

3,903

2,946

2,296

2,190

1,939

2,007

2,079

2,111

0

0

0

General and administrative

16,386

17,035

17,233

19,184

17,205

19,612

21,677

19,894

15,709

15,064

15,193

16,034

16,708

16,494

15,898

14,567

13,674

13,291

12,624

12,369

10,093

8,287

7,275

6,115

5,279

5,127

5,136

4,502

0

0

0

Sales and marketing

4,723

4,721

4,785

5,268

3,850

4,831

5,610

4,990

4,374

4,127

4,341

4,668

5,457

5,646

5,451

5,269

4,769

4,596

4,331

3,964

3,294

2,666

2,194

1,842

1,634

1,525

1,455

1,398

0

0

0

Impairment of goodwill

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Merger costs

0

-

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

29,661

28,041

28,312

30,724

24,351

27,830

31,647

29,673

24,324

24,045

25,079

26,669

28,118

28,301

27,086

25,319

24,308

23,341

22,258

20,955

17,290

13,899

11,766

10,147

8,854

8,661

8,671

8,013

0

0

0

Loss from continuing operations

-19,645

-19,284

-19,949

-21,978

-19,226

-19,115

-20,768

-18,622

-12,599

-13,454

-14,342

-16,724

-20,404

-21,995

-22,408

-21,377

-20,152

-19,427

-19,424

-19,209

-15,995

-12,767

-10,089

-8,462

-7,632

-7,662

-8,162

-7,640

0

0

0

Other income (expense):
Interest expense

4,236

4,118

3,606

2,120

1,654

1,922

2,173

2,128

907

668

522

454

460

461

436

344

292

217

165

473

756

1,076

1,435

2,388

3,480

4,436

5,130

4,701

0

0

0

Interest income

0

0

0

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

-80

-62

-119

-136

-140

-258

-207

42

81

168

114

-152

-479

-776

-393

-269

-107

208

-108

-198

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of other derivatives

0

0

-55

-86

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

36

23

39

40

40

49

47

61

64

74

82

66

51

30

0

0

0

-

-

-

-

Change in fair value of warrant liability

1,107

1,085

3,033

3,732

4,821

7,599

6,022

-1,964

-3,131

-5,209

-5,786

1,525

746

248

67

35

111

26

446

417

0

0

0

-

-

-

11,257

7,538

0

0

0

Change in fair value of siParadigm Earn-Out

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

266

46

371

371

325

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt conversion costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Total other income (expense)

-4,040

-3,035

-585

1,605

3,056

5,749

3,903

-4,337

-4,126

-6,383

-6,757

921

479

603

64

9

-27

-337

452

216

186

-1,310

-8,943

-4,575

-6,923

-3,516

4,265

974

0

0

0

Loss before income taxes

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-22,959

-16,725

-19,837

-21,099

-15,803

0

0

0

-

-

-

-

-18,993

0

0

0

-

-

-

-

-6,665

0

0

0

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Income tax benefit

0

0

-

-

0

0

-

-2,079

-970

-970

-970

0

0

0

0

-

-

-

-

-2,350

-1,814

-1,814

-1,814

-664

0

0

0

-

-

-

-

Loss from continuing operations

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-10,180

-20,674

-20,534

-20,373

-24,509

-16,623

-15,756

-20,880

-15,755

-18,867

-20,129

-15,803

-18,741

-20,208

-21,160

-20,184

-19,643

-19,228

-18,435

-16,643

-13,994

-12,263

-17,219

-12,373

-13,892

-10,514

-3,232

-6,665

0

0

0

Foreign currency translation gain (loss)

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-0.03

-0.14

-

-

-0.23

-0.28

-

-

-0.54

-

-0.44

-0.54

-0.50

-0.45

-0.27

-1.50

-0.61

-2.29

1.75

-3.01

0.23

-1.38

-0.81

Diluted net (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-0.15

-0.16

-

-

-0.23

-0.28

-

-

-0.56

-

-0.44

-0.55

-0.51

-0.47

-0.27

1.44

-0.61

-2.29

-2.18

-4.15

-2.23

-2.32

-1.85

Basic weighted-average shares outstanding (in shares)

-

-

-

-

-

-

-

-

21,577

19,697

-

-

16,519

14,538

-

-

9,726

-

9,704

9,640

9,575

9,302

9,276

8,268

5,055

3,985

1,349

1,347

1,346

1,346

1,329

Diluted weighted-average shares outstanding (in shares)

-

-

-

-

-

-

-

-

22,359

20,663

-

-

16,519

14,538

-

-

9,728

-

9,704

9,676

9,575

9,318

9,276

8,312

5,055

3,985

1,349

1,166

1,355

1,429

1,433

Foreign currency translation (loss)

-

-

0

-

-

-

0

-

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive income (loss)

-10,385

-20,789

-20,599

-20,382

-24,404

-16,489

-15,707

-20,811

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share from continuing operations (usd per share)

-2.38

-0.01

-

-

-3.77

0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per share from discontinuing operations (usd per share)

3.36

-0.06

-

-

-5.57

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per share (usd per share)

0.98

-0.07

-0.09

8.88

-9.34

-0.13

-0.16

-

-

-

-0.51

-

-

-

-0.39

-

-

-0.51

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted weighted-average shares outstanding

2,014

57,164

48,933

54,154

912

27,049

27,049

-

-

-

18,904

-

-

-

13,547

-

-

9,715

-

-

-

-

-

-

-

-

-

-

-

-

-